Nitric Oxide Drugs & Therapeutics Market

Nitric Oxide Drugs & Therapeutics Market by Drug Type, Therapy, Application, End-User, and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032

3.8%

CAGR (2026-2032)

4.33 USD Bn.

Market Size

322

Report Pages

139

Market Tables

Overview

The Nitric Oxide Drugs & Therapeutics Market size was valued at USD 4.33 Billion in 2025 and the total Nitric Oxide Drugs & Therapeutics revenue is expected to grow at a CAGR of 3.8% from 2025 to 2032, reaching nearly USD 5.62 Billion by 2032.

Nitric Oxide Drugs & Therapeutics Market Overview:

Nitric oxide is a colourless, tasteless, and short-acting gas, which widens blood vessels in the lungs when inhaled. It is a key signalling molecule in the cardiovascular, immune and Central nervous systems. It is frequently used as the first line of treatment for oxygen-deprived premature babies.

Nitric Oxide Drugs & Therapeutics Market Dynamics:

The rising prevalence of neural disorders, respiratory disorders, and cardiovascular disorders are the major factors driving the market growth.

The rise in the number of patients with chronic obstructive pulmonary disease (COPD) and acute respiratory diseases boost the growth of global nitric oxide drugs & the therapeutics market. Owing to its antiviral property and improved oxygenation nitric oxide is now being tested as an experimental treatment for COVID-19. Along with this, rising patient awareness, growing geriatric population, increasing research activities for developing novel therapeutic drugs are some factors that will help in augmenting the market growth. In addition to this, nitric oxide is also majorly used in the treatment of penile dysfunction. Nitric oxide played a central role in the development of the erectile dysfunction drug Viagra.

The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.
To know about the Research Methodology :- Request Free Sample Report

Nitric Oxide Drugs & Therapeutics Market Segment Analysis:

The global Nitric Oxide Drugs & Therapeutics Market is segmented based on drug type, therapy, application, and end-users.

Based on Therapy, the Inhalation therapy segment is expected to grow rapidly during the forecast period at a CAGR of 7.9%. The segment growth is anticipated due to the growing prevalence of respiratory disorders, breathing problems in neonates, and its current experimental use in the treatment of COVID-19 for the frontline workers contributes to the growth of the segment. On-going clinical trials, technological advancements, and new product launches are likely to create potential opportunities during the forecast period. Mallinckrodt has initiated a retrospective study for the use of inhaled nitric oxide in COVID-19 patients.

Nitric Oxide Drugs & Therapeutics Market Regional Insights:

North America is expected to dominate the global market during the forecast period.

Most of the commercial developments of nitric oxide-based products are rapidly growing in the North American region, followed by Europe in the second place. Owing to the widespread application of nitric oxide in health & disease, nitric oxide-based therapies and products are developed and are approved in the USA and Europe, and they are expected to be the prominent players in the international markets in a very short time period. In addition to this, favorable government policies and increased funding for research activities help in propelling the market growth.

APAC is expected to be the fastest growing region.

Rising awareness among patients, increasing healthcare expenditure, changing lifestyle, the prevalence of respiratory and cardiovascular disorders are the key factors driving the market growth in the region. Well-developed medical infrastructure in the countries like India, China, Japan, and an increasing number of pharmaceutical companies in these countries also add up to the market growth.

The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.

Nitric Oxide Drugs & Therapeutics Market scope: Inquire before buying

Global Nitric Oxide Drugs & Therapeutics Market
Report Coverage	Details
Base Year:	2025	Forecast Period:	2026-2032
Historical Data:	2020 to 2025	Market Size in 2025:	USD 4.33 Bn.
Forecast Period 2026 to 2032 CAGR:	3.8%	Market Size in 2032:	USD 5.62 Bn.
Segments Covered:	by Drug Type	Inorganic drugs Donating drugs Hybrid drugs Others
	by Therapy	Inhalation therapy Gene therapy Vascular therapy Others
	by Application	Inflammatory disorders Cardiovascular diseases Erectile dysfunction Neuroprotection
	by End-User	Diagnostic laboratories Pathology labs Research lab

Nitric Oxide Drugs & Therapeutics Market, by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Nitric Oxide Drugs & Therapeutics Market, Key Players are:

1. Third Pole, Inc.
2. Novan, Inc.
3. Mallinckrodt
4. Pulmonox Group
5. AOBiome, LLC.
6. Novoteris, LLC.
7. Neogenis, Inc.
8. Bellerophone Therapeutics
9. BOC Healthcare
10. Dan Hammer Health Ltd.
11. EKU Elektronik
12. GeNO LLC
13. International Biomedical
14. Praxair Inc.
15. Vapotherm

Frequently Asked Questions:

1. Which region has the largest share in Global Nitric Oxide Drugs & Therapeutics Market?
Ans: North America region held the highest share in 2025.

2. What is the growth rate of Global Market?
Ans: The Global Market is growing at a CAGR of 3.8% during forecasting period 2026-2032.

3. What is scope of the Global Market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Nitric Oxide Drugs & Therapeutics Market?
Ans: The important key players in the Global Nitric Oxide Drugs & Therapeutics Market are – Third Pole, Inc., Novan, Inc., Mallinckrodt, Pulmonox Group, AOBiome, LLC., Novoteris, LLC., Neogenis, Inc., Bellerophone Therapeutics, BOC Healthcare, Dan Hammer Health Ltd., EKU Elektronik, GeNO LLC, International Biomedical, Praxair Inc., and Vapotherm.

5. What is the study period of this Market?
Ans: The Global Nitric Oxide Drugs & Therapeutics Market is studied from 2025 to 2032.

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Nitric Oxide Drugs & Therapeutics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Nitric Oxide Drugs & Therapeutics Market 3.4. Geographical Snapshot of the Nitric Oxide Drugs & Therapeutics Market, By Manufacturer share 4. Global Nitric Oxide Drugs & Therapeutics Market Overview, 2025-2032 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Nitric Oxide Drugs & Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Nitric Oxide Drugs & Therapeutics Market Analysis and Forecast, 2025-2032 6.1. Global Nitric Oxide Drugs & Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 7.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 7.1.1. Inorganic drugs 7.1.2. Donating drugs 7.1.3. Hybrid drugs 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 7.2.1. Inhalation therapy 7.2.2. Gene therapy 7.2.3. Vascular therapy 7.2.4. Others 7.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 7.3.1. Inflammatory disorders 7.3.2. Cardiovascular diseases 7.3.3. Erectile dysfunction 7.3.4. Neuroprotection 7.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 7.4.1. Diagnostic laboratories 7.4.2. Pathology labs 7.4.3. Research lab 8. Global Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2025-2032 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 9.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 9.1.1. Inorganic drugs 9.1.2. Donating drugs 9.1.3. Hybrid drugs 9.1.4. Others 9.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 9.2.1. Inhalation therapy 9.2.2. Gene therapy 9.2.3. Vascular therapy 9.2.4. Others 9.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 9.3.1. Inflammatory disorders 9.3.2. Cardiovascular diseases 9.3.3. Erectile dysfunction 9.3.4. Neuroprotection 9.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 9.4.1. Diagnostic laboratories 9.4.2. Pathology labs 9.4.3. Research lab 10. North America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2025-2032 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 11.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 11.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 11.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 11.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 12. Canada Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 12.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 12.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 12.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 12.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 13. Mexico Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 13.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 13.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 13.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 13.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 14. Europe Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 14.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 14.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 14.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 14.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 15. Europe Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2025-2032 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 16.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 16.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 16.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 16.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 17. France Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 17.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 17.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 17.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 17.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 18. Germany Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 18.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 18.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 18.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 18.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 19. Italy Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 19.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 19.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 19.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 19.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 20. Spain Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 20.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 20.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 20.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 20.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 21. Sweden Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 21.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 21.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 21.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 21.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 22. CIS Countries Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 22.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 22.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 22.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 22.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 23. Rest of Europe Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 23.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 23.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 23.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 23.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 24. Asia Pacific Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 24.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 24.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 24.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 24.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 25. Asia Pacific Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2025-2032 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 26.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 26.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 26.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 26.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 27. India Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 27.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 27.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 27.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 27.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 28. Japan Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 28.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 28.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 28.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 28.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 29. South Korea Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 29.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 29.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 29.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 29.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 30. Australia Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 30.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 30.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 30.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 30.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 31. ASEAN Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 31.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 31.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 31.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 31.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 32. Rest of Asia Pacific Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 32.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 32.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 32.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 32.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 33. Middle East Africa Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 33.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 33.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 33.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 33.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 34. Middle East Africa Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2025-2032 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 35.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 35.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 35.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 35.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 36. GCC Countries Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 36.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 36.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 36.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 36.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 37. Egypt Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 37.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 37.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 37.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 37.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 38. Nigeria Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 38.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 38.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 38.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 38.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 39. Rest of ME&A Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 39.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 39.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 39.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 39.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 40. South America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 40.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 40.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 40.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 40.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 41. South America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2025-2032 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 42.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 42.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 42.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 42.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 43. Argentina Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 43.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 43.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 43.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 43.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 44. Rest of South America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2025-2032 44.1. Market Size (Value) Estimates & Forecast By Drug Type, 2025-2032 44.2. Market Size (Value) Estimates & Forecast By Therapy, 2025-2032 44.3. Market Size (Value) Estimates & Forecast By Application, 2025-2032 44.4. Market Size (Value) Estimates & Forecast By End users, 2025-2032 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Nitric Oxide Drugs & Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Third Pole, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Novan, Inc. 45.3.3. Mallinckrodt 45.3.4. Pulmonox Group 45.3.5. AOBiome, LLC. 45.3.6. Novoteris, LLC. 45.3.7. Neogenis, Inc. 45.3.8. Bellerophone Therapeutics 45.3.9. BOC Healthcare 45.3.10. Dan Hammer Health Ltd. 45.3.11. EKU Elektronik 45.3.12. GeNO LLC 45.3.13. International Biomedical 45.3.14. Praxair Inc. 45.3.15. Vapotherm 46. Primary Key Insights

Global Nitric Oxide Drugs & Therapeutics Market

Choose License Type